AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36

Authors: TONATO M GRALLA RJ ROILA F
Citation: M. Tonato et al., INTERNATIONAL (PERUGIA) CONSENSUS ON ANTIEMETIC THERAPY - INTRODUCTION, Supportive care in cancer, 6(3), 1998, pp. 193-193

Authors: HESKETH PJ GRALLA RJ DUBOIS A TONATO M
Citation: Pj. Hesketh et al., METHODOLOGY OF ANTIEMETIC TRIALS - RESPONSE ASSESSMENT, EVALUATION OFNEW AGENTS AND DEFINITION OF CHEMOTHERAPY EMETOGENICITY, Supportive care in cancer, 6(3), 1998, pp. 221-227

Authors: GANDARA DR ROILA F WARR D EDELMAN MJ PEREZ EA GRALLA RJ
Citation: Dr. Gandara et al., CONSENSUS PROPOSAL FOR 5HT(3) ANTAGONISTS IN THE PREVENTION OF ACUTE EMESIS RELATED TO HIGHLY EMETOGENIC CHEMOTHERAPY - DOSE, SCHEDULE, ANDROUTE OF ADMINISTRATION, Supportive care in cancer, 6(3), 1998, pp. 237-243

Authors: ROILA F DELFAVERO A GRALLA RJ TONATO M AAPRO MS ANDREWS PLR BALLATORI E DEMULDER PHM DICATO MA DUBOIS A FEYER PC GANDARA DR GRALLA RJ GRALLA RJ GROSHEN S GRUNBERG SM HERRSTEDT J HESKETH PJ JOSS RA KRIS MG MARTY MM MORROW GR NAYLOR RJ OLVER IN SMYTH JF SPITZER TR STEWART A
Citation: F. Roila et al., PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE, Annals of oncology, 9(8), 1998, pp. 811-819

Authors: RITTER HL GRALLA RJ HALL SW WADA JK FRIEDMAN C HAND L FITTS D
Citation: Hl. Ritter et al., EFFICACY OF INTRAVENOUS GRANISETRON TO CONTROL NAUSEA AND VOMITING DURING MULTIPLE CYCLES OF CISPLATIN-BASED CHEMOTHERAPY, Cancer investigation, 16(2), 1998, pp. 87-93

Authors: GRALLA RJ NAVARI RM HESKETH PJ POPOVIC W STRUPP J NOY J EINHORN L ETTINGER D BUSHNELL W FRIEDMAN C
Citation: Rj. Gralla et al., SINGLE-DOSE ORAL GRANISETRON HAS EQUIVALENT ANTIEMETIC EFFICACY TO INTRAVENOUS ONDANSETRON FOR HIGHLY EMETOGENIC CISPLATIN-BASED CHEMOTHERAPY, Journal of clinical oncology, 16(4), 1998, pp. 1568-1573

Authors: GRALLA RJ
Citation: Rj. Gralla, ANTIEMETIC THERAPY, Seminars in oncology, 25(5), 1998, pp. 577-583

Authors: GRALLA RJ GRUSENMEYER PA
Citation: Rj. Gralla et Pa. Grusenmeyer, COMPARING THE COSTS AND COST-EFFECTIVENESS OF NEW CHEMOTHERAPY REGIMENS FOR TREATING NONSMALL CELL LUNG-CANCER (NSCLC), European journal of cancer, 33, 1997, pp. 26-26

Authors: GRUSENMEYER PA GRALLA RJ TRAPANI MM BATEMAN NM
Citation: Pa. Grusenmeyer et al., COST CONSIDERATIONS IN ALTERNATIVES TO INPATIENT CARE IN THE ADMINISTRATION OF CHEMOTHERAPY AND SUPPORTIVE CARE, European journal of cancer, 33, 1997, pp. 28-28

Authors: GRALLA RJ
Citation: Rj. Gralla, ANTI-EMESIS WITH CANCER-CHEMOTHERAPY, European journal of cancer, 33, 1997, pp. 63-67

Authors: BALLATORI E ROILA F DEANGELIS V CICCARESE G PALLADINO MA TONATO M DELFAVERO A HERRSTEDT J DICATO M DUBOIS A HESKETH P KRIS M GRALLA RJ
Citation: E. Ballatori et al., CLINICAL AND METHODOLOGICAL ISSUES IN ANTIEMETIC THERAPY - A WORLDWIDE SURVEY OF EXPERTS OPINIONS, Supportive care in cancer, 5(4), 1997, pp. 269-273

Authors: PEREZ EA NAVARI RM KAPLAN HG GRALLA RJ GRUNBERG SM PALMER RH FITTS D
Citation: Ea. Perez et al., EFFICACY AND SAFETY OF DIFFERENT DOSES OF GRANISETRON FOR THE PROPHYLAXIS OF CISPLATIN-INDUCED EMESIS, Supportive care in cancer, 5(1), 1997, pp. 31-37

Authors: HOLLEN PJ GRALLA RJ COX C EBERLY SW KRIS MG
Citation: Pj. Hollen et al., A DILEMMA IN ANALYSIS - ISSUES IN THE SERIAL MEASUREMENT OF QUALITY-OF-LIFE IN PATIENTS WITH ADVANCED LUNG-CANCER, Lung cancer, 18(2), 1997, pp. 119-136

Authors: RUBENSTEIN EB GRALLA RJ HAINSWORTH JD HESKETH PJ GROTE TH MODIANO MR KHOJASTEH A KALMAN LA BENEDICT CR HAHNE WF
Citation: Eb. Rubenstein et al., RANDOMIZED, DOUBLE-BLIND, DOSE-RESPONSE TRIAL ACROSS 4 ORAL DOSES OF DOLASETRON FOR THE PREVENTION OF ACUTE EMESIS AFTER MODERATELY EMETOGENIC CHEMOTHERAPY, Cancer, 79(6), 1997, pp. 1216-1224

Authors: CRAWFORD J CHANG AY GRALLA RJ SOUQUET PJ VOKES EE
Citation: J. Crawford et al., COMBINATION REGIMENS AND DOSE INTENSIFICATION IN NON-SMALL-CELL LUNG-CANCER - A PANEL DISCUSSION .1., Seminars in oncology, 23(2), 1996, pp. 22-24

Authors: HOLLEN PJ GRALLA RJ
Citation: Pj. Hollen et Rj. Gralla, COMPARISON OF INSTRUMENTS FOR MEASURING QUALITY-OF-LIFE IN PATIENTS WITH LUNG-CANCER, Seminars in oncology, 23(2), 1996, pp. 31-40

Authors: CRAWFORD J DUCH DS GRALLA RJ HILLNER BE HOLLEN PJ VOKES EE
Citation: J. Crawford et al., PHARMACOECONOMICS, QUALITY-OF-LIFE, AND COMBINATION MODALITIES IN NON-SMALL-CELL LUNG-CANCER - A PANEL DISCUSSION .2., Seminars in oncology, 23(2), 1996, pp. 53-55

Authors: GRALLA RJ RITTENBERG C PERALTA M LETTOW L CRONIN M
Citation: Rj. Gralla et al., CISPLATIN AND EMESIS - ASPECTS OF TREATMENT AND A NEW TRIAL FOR DELAYED EMESIS USING ORAL DEXAMETHASONE PLUS ONDANSETRON BEGINNING AT 16 HOURS AFTER CISPLATIN, Oncology, 53, 1996, pp. 86-91

Authors: KRIS MG CUBEDDU LX GRALLA RJ CUPISSOL D TYSON LB VENKATRAMAN E HOMESLEY HD
Citation: Mg. Kris et al., ARE MORE ANTIEMETIC TRIALS WITH A PLACEBO NECESSARY - REPORT OF PATIENT DATA FROM RANDOMIZED TRIALS OF PLACEBO ANTIEMETICS WITH CISPLATIN, Cancer, 78(10), 1996, pp. 2193-2198

Authors: VOKES EE ROSENBERG RK JAHANZEB M CRAIG JB GRALLA RJ BELANI CP JONES SE BIGLEY JW HOHNEKER JA
Citation: Ee. Vokes et al., MULTICENTER PHASE-II STUDY OF WEEKLY ORAL VINORELBINE FOR STAGE-IV NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 13(3), 1995, pp. 637-644

Authors: RIVERA MP KRIS MG GRALLA RJ WHITE DA
Citation: Mp. Rivera et al., SYNDROME OF ACUTE DYSPNEA RELATED TO COMBINED MITOMYCIN PLUS VINCA ALKALOID CHEMOTHERAPY, American journal of clinical oncology, 18(3), 1995, pp. 245-250

Authors: KRIS MG PISTERS KMW GINSBERG RJ RIGAS JR MILLER VA GRANT SC GRALLA RJ HEELAN RT MARTINI N
Citation: Mg. Kris et al., EFFECTIVENESS AND TOXICITY OF PREOPERATIVE THERAPY IN STAGE IIIA NONSMALL CELL LUNG-CANCER INCLUDING THE MEMORIAL SLOAN-KETTERING EXPERIENCE WITH INDUCTION MVP IN PATIENTS WITH BULKY MEDIASTINAL LYMPH-NODE METASTASES (CLINICAL N2), Lung cancer, 12, 1995, pp. 47-57

Authors: GRALLA RJ
Citation: Rj. Gralla, EDATREXATE STUDIES IN NONSMALL CELL LUNG-CANCER, Lung cancer, 12, 1995, pp. 187-191

Authors: CLERI LB KRIS MG TYSON LB PISTERS KMW CLARK RA GRALLA RJ
Citation: Lb. Cleri et al., ORAL COMBINATION ANTIEMETICS IN PATIENTS WITH SMALL-CELL LUNG-CANCER RECEIVING CISPLATIN OR CYCLOPHOSPHAMIDE PLUS DOXORUBICIN, Cancer, 76(5), 1995, pp. 774-778

Authors: GRALLA RJ
Citation: Rj. Gralla, ANTIEMETIC TREATMENT FOR CANCER-CHEMOTHERAPY - PROBLEMS AND PROGRESS, Supportive care in cancer, 2(5), 1994, pp. 275-276
Risultati: 1-25 | 26-36